Dr. David Cella from Northwestern University Feinberg School of Medicine on Patient-Reported Outcomes in a Clinical Setting
David Cella, PhD
Advertisement
Articles by David Cella, PhD
Dr. David Cella from Northwestern University Feinberg School of Medicine on the Value of Patient-Reported Outcomes
Dr. David Cella from Northwestern University Feinberg School of Medicine on Quality of Life Assessments' Cost Effectiveness
Dr. David Cella from Northwestern University Feinberg School of Medicine Explains the Increase in Quality of Life Assessments
Dr. David Cella from Northwestern University Feinberg School of Medicine on the Side Effect Focus of the Axitinib and Sorafenib Trial
Dr. Cella From Northwestern University Feinberg School of Medicine Discusses Axitinib and Sorafenib Axis Trial
Dr. Cella from Northwestern University Feinberg School of Medicine on Patient Assessment Reference Scores
Advertisement
Latest Updated Articles
Dr. Cella Discusses Axitinib and Sorafenib Axis TrialJune 17th 2011
Dr. Cella on the Increase in Quality of Life AssessmentsJune 24th 2011
Dr. Cella on Patient Reported Data's Cost EffectivenessJune 29th 2011
Dr. Cella on the Value of Patient-Reported OutcomesJuly 6th 2011
Advertisement
Advertisement
Trending on OncLive
1
HERIZON-GEA-01 PD-L1 Subgroup Data Support Zanidatamab Combo as a New Frontline SOC in HER2+ GEA
2
TALAPRO-3 Shows Talazoparib Plus Enzalutamide Improves rPFS in HRR-Altered mCSPC
3
Selinexor Plus Ruxolitinib Yields Superior Spleen Responses, OS Signal in JAK Inhibitor–Naïve Myelofibrosis
4
Dr Eads on Early Data for CDH17-Directed CAR T-Cell Therapy in R/R GI Cancers
5